ClinicalTrials.Veeva

Menu

The Role of a Semi-Quantitative Urine Pregnancy Test and Pregnancy Questionnaire After Uterine Evacuation for Undesired Pregnancy of Uncertain Location

P

Planned Parenthood League of Massachusetts

Status

Completed

Conditions

Follow-up After Uterine Evacuation

Treatments

Device: dBest semi-quantitative urine pregnancy test

Study type

Interventional

Funder types

Other

Identifiers

NCT01596972
2012P000576

Details and patient eligibility

About

The primary aim of this study is to determine if a self-administered semi-quantitative urine pregnancy test and telephone pregnancy symptom questionnaire can reduce the percentage of women with a complete uterine evacuation who require a clinic or lab visit to confirm completion.

The investigators hypothesize that women with complete uterine evacuation will be less likely to require a follow-up clinic or lab visit by using a standardized pregnancy questionnaire and home SQ-UPT, than by using serum hCG as the objective measure of completion.

Enrollment

51 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women aged 18 years or older with an undesired pregnancy < 6 weeks gestation
  • Women with a positive urine pregnancy test
  • Proficiency in English
  • Working phone and subject willing to be contacted by phone.
  • Agreeing to surveys regarding demographics, follow-up preferences, and satisfaction with assigned follow-up method

Exclusion criteria

  • Women with presence of a yolk sac or crown rump length visualized on ultrasound

  • Women with a gestational sac greater than 13mm [11]

  • High Suspicion for ectopic pregnancy

    o Sign: Concerning adnexal mass seen on ultrasound in conjunction with pelvic pain and/or vaginal spotting

  • Hemodynamic instability

    o Signs: heavy vaginal bleeding, hypotension, tachycardia

  • Pelvic Infection

    o Signs: pain or fever

  • Medical conditions that contraindicate uterine evacuation according to PPLM clinic policy

    o These include but are not limited to: a bleeding disorder or anticoagulation, significant cardiac disease, renal or liver failure, IUD in situ that cannot be removed

  • Unwilling or unable to comply with study follow-up procedures

  • Being in a situation where receiving phone calls or additional contact with research staff may endanger the privacy or safety of the subject (e.g. situations of domestic violence or abuse)

  • Inability to give informed consent

  • Previous participation in this study

Trial design

51 participants in 2 patient groups

Serum quantitative urine pregnancy test
Experimental group
Description:
uterine evacuation follow-up consisting of an at-home, self-administered SQ-UPT and standardized pregnancy symptom questionnaire in 1 week
Treatment:
Device: dBest semi-quantitative urine pregnancy test
serum hCG
No Intervention group
Description:
follow-up consisting of a 1 week return visit and serum hCG plus standardized pregnancy symptom questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems